Australian-Singaporean medical technology company Osteopore Limited (ASX: OSX; Osteopore or Company) is pleased to announce a strengthening of its leadership team with the appointment of the Hon. Michael Keenan as a Non-Executive Director and the promotion of Dr Lim Jing to the role of Chief Executive Officer (CEO), effective 18 July 2023.
HIGHLIGHTS
- Former Australian Government Cabinet Minister Hon. Michael Keenan joins the Board as Non-Executive Director.
- Osteopore Chief Operating Officer (COO) and Chief Technology Officer (CTO) Dr Lim Jing is promoted to Chief Executive Officer (CEO).
- Osteopore’s current CEO Goh Khoon Seng appointed to the newly created position of Global Marketing Director to drive commercial growth.
Mr Keenan served as a Federal Member of Parliament from 2004 to 2019 and held senior ministry positions in the Abbott, Turnbull and Morrison Governments between 2013 to 2019. Mr Keenan’s ministerial portfolios included Human Services – responsible for providing direction and oversight of Medicare – Justice, Counter-Terrorism and Digital Transformation.
Perth-based Mr Keenan brings a wealth of experience and knowledge in public policy and corporate governance to Osteopore. Mr Keenan’s appointment further strengthens the Company’s presence in Australia.
Mr Keenan serves on the Board of U Group and Co and the Australian Strategic Policy Institute.
